These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16601124)

  • 21. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
    Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
    Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes.
    Pan J; Fukuda K; Saito M; Matsuzaki J; Kodama H; Sano M; Takahashi T; Kato T; Ogawa S
    Circ Res; 1999 May; 84(10):1127-36. PubMed ID: 10347087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TWEAK signals through JAK-STAT to induce tumor cell apoptosis.
    Chapman MS; Wu L; Amatucci A; Ho SN; Michaelson JS
    Cytokine; 2013 Jan; 61(1):210-7. PubMed ID: 23107828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.
    Dos Santos RS; Guzman-Llorens D; Perez-Serna AA; Nadal A; Marroqui L
    Front Immunol; 2023; 14():1263926. PubMed ID: 37854597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
    Herrmann A; Lahtz C; Nagao T; Song JY; Chan WC; Lee H; Yue C; Look T; Mülfarth R; Li W; Jenkins K; Williams J; Budde LE; Forman S; Kwak L; Blankenstein T; Yu H
    Cancer Res; 2017 Sep; 77(18):5118-5128. PubMed ID: 28716895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons.
    Li Y; Batra S; Sassano A; Majchrzak B; Levy DE; Gaestel M; Fish EN; Davis RJ; Platanias LC
    J Biol Chem; 2005 Mar; 280(11):10001-10. PubMed ID: 15644321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major differences in the responses of primary human leukocyte subsets to IFN-beta.
    van Boxel-Dezaire AH; Zula JA; Xu Y; Ransohoff RM; Jacobberger JW; Stark GR
    J Immunol; 2010 Nov; 185(10):5888-99. PubMed ID: 20956346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
    Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
    J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine kinase 2 interacts with the proapoptotic protein Siva-1 and augments its apoptotic functions.
    Shimoda HK; Shide K; Kameda T; Matsunaga T; Shimoda K
    Biochem Biophys Res Commun; 2010 Sep; 400(2):252-7. PubMed ID: 20727854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes.
    Sakamoto S; Potla R; Larner AC
    J Biol Chem; 2004 Sep; 279(39):40362-7. PubMed ID: 15194680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation.
    Ho HH; Ivashkiv LB
    J Biol Chem; 2006 May; 281(20):14111-8. PubMed ID: 16571725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirement of catalytically active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta.
    Rani MR; Pandalai S; Shrock J; Almasan A; Ransohoff RM
    J Interferon Cytokine Res; 2007 Sep; 27(9):767-79. PubMed ID: 17892398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus.
    Strobl B; Bubic I; Bruns U; Steinborn R; Lajko R; Kolbe T; Karaghiosoff M; Kalinke U; Jonjic S; Müller M
    J Immunol; 2005 Sep; 175(6):4000-8. PubMed ID: 16148148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hapten-induced contact hypersensitivity is enhanced in Tyk2-deficient mice.
    Hosogi M; Tonogaito H; Aioi A; Hamada K; Shimoda K; Muromoto R; Matsuda T; Miyachi Y
    J Dermatol Sci; 2004 Oct; 36(1):51-6. PubMed ID: 15488705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
    Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
    Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell.
    Ho LJ; Hung LF; Weng CY; Wu WL; Chou P; Lin YL; Chang DM; Tai TY; Lai JH
    J Immunol; 2005 Jun; 174(12):8163-72. PubMed ID: 15944325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway.
    Gamero AM; Larner AC
    J Biol Chem; 2001 Apr; 276(17):13547-53. PubMed ID: 11278370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2.
    Rani MR; Gauzzi C; Pellegrini S; Fish EN; Wei T; Ransohoff RM
    J Biol Chem; 1999 Jan; 274(4):1891-7. PubMed ID: 9890942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.